Advertisment
|
|
|
news roundup
A recent analysis finds that pre-market development time for breakthrough-designated drugs is 2.2 years shorter than for those without.
advertisment
Immuno-Oncology Insights:
Top 5 Challenges in Today's Immuno-Oncology Trials
On Demand
click here
|
The Covance Central Laboratory in Geneva provides services for global clinical trials in Europe and Africa.
advertisment
Overcoming regulatory and statistical hurdles of biosimilars drug development
Designing smarter trials
On Demand
click here
|
Agreement combines PAREXEL’s LIQUENT InSight RIM platform and EMC's Documentum.
advertisment
Mitigating risk using Risk-based Monitoring On Demand Learn how risk-based monitoring (RBM) is transforming clinical development by mitigating risk while optimizing execution. Understand how to achieve enhanced patient safety with improved quality to execute your RBM studies with confidence.
click here
|
Updated people moves and company awards.
|
|
|
advertisment
|
|
Subscribe
|
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
|
|
Blog Posts
Mike Graziano, VP of Toxicology at Bristol-Myers Squibb, will elaborate on Biocelerate's toxicology data sharing initiative.
Pharmacists have new prominence in a new European system, created jointly with drugmakers and wholesalers and parallel traders.
|
|
mHealth
There has been an increased interest in the potential of e-health and m-health in low- and middle-income countries.
A significant increase in usage of wearables and devices to collect patient data in clinical trials is likely as these devices can provide data such as mobility, sleep, heart rate that would otherwise be unavailable.
|
|
|
advertisment
|
|
Articles
Governments and patient advocate organizations can incentivize pharmaceutical companies that engage in orphan drug development.
|
|
|
|
Read the digital edition of Applied Clinical Trials Click here to sign up or renew your subscription
|
|
|
|
|